Thyroid Cancer in Surgical Treated Multinodular Goiter
Thyroid Cancer in Surgically Treated Multinodular Goiter: Incidence and Histopatological Outcomes
1 other identifier
observational
223
1 country
1
Brief Summary
This study aims to investigate, based on existing knowledge, the incidence of occult thyroid carcinoma in a cohort of patients with MNG, providing new insights into the prevalence and characteristics of thyroid malignancies in MNG. It seeks to contribute to optimizing diagnostic evaluations for patients with multinodular goiter.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedFirst Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 11, 2025
CompletedApril 11, 2025
April 1, 2025
6.4 years
March 28, 2025
April 4, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of occult thyroid carcinoma
Incidence of occult thyroid carcinoma in a cohort of patients with multinodular goiter, providing new insights into the prevalence and characteristics of thyroid malignancies.
6 years
Study Arms (1)
Patient with multinodular goiter who underwent total or partial thyroidectomy
Interventions
Total thyroidectomy is a surgical procedure that involves the complete removal of the thyroid gland. It is performed to treat conditions such as thyroid cancer, large goiters, or severe hyperthyroidism. The surgery is typically conducted under general anesthesia through an incision in the lower neck. Postoperative management may include hormone replacement therapy with levothyroxine to compensate for the loss of thyroid function. Potential complications include hypocalcemia due to parathyroid gland injury and vocal cord dysfunction from recurrent laryngeal nerve damage.
Eligibility Criteria
Patients of both sex with cancer incidence in multinodular thyroid goiter who underwent surgery in the same center
You may qualify if:
- patients diagnosed with multinodular goiter via thyroid ultrasound, with or without FNA cytology.
- patients who underwent surgery.
- availability of complete clinical data
You may not qualify if:
- history of thyroid carcinoma or other thyroid neoplasms.
- not completed postoperative follow up.
- patients with preoperative FNA results indicating malignancy (TIR 4-5), suspicion of malignancy (TIR 3), or indeterminate significance (TIR 1)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Foggia
Foggia, FG, 71122, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 11, 2025
Study Start
January 1, 2018
Primary Completion
May 30, 2024
Study Completion
July 31, 2024
Last Updated
April 11, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share